Di Fu Selected Research

Di Fu Research Topics

Disease

13	Lymphoma (Lymphomas) 01/2024 - 01/2018
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 06/2019
11	Neoplasms (Cancer) 08/2023 - 01/2018
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2024 - 01/2021
4	Infections 01/2023 - 08/2008
4	Rheumatoid Arthritis 02/2013 - 03/2011
3	Disease Progression 04/2023 - 08/2008
3	Pain (Aches) 01/2023 - 05/2013
2	Neuralgia (Stump Neuralgia) 01/2023 - 05/2013
2	Inflammation (Inflammations) 01/2023 - 10/2022
2	Hypersensitivity (Allergy) 01/2023 - 05/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2019
1	Sepsis (Septicemia) 04/2024
1	Periodontal Diseases (Periodontal Disease) 01/2024
1	Drowning 12/2023
1	Osteosarcoma (Osteogenic Sarcoma) 10/2023
1	Infarction (Infarctions) 01/2023
1	Febrile Neutropenia 01/2023
1	Aortic Dissection 01/2023
1	Myocardial Infarction 01/2023
1	Neutropenia 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Body Weight (Weight, Body) 12/2022
1	Lymphadenopathy 12/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Periodontitis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Epstein-Barr Virus Infections 12/2021
1	Cardiotoxicity 06/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2024 - 01/2021
4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2006
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
3	ChemokinesIBA 04/2023 - 03/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 08/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2009 - 03/2006
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 03/2024 - 01/2023
2	Metformin (Glucophage)FDA LinkGeneric 04/2023 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2023
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 06/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2022
2	Decitabine FDA Link 12/2021 - 01/2018
2	Epirubicin (Ellence)FDA LinkGeneric 12/2021 - 06/2019
2	Simvastatin (Zocor)FDA LinkGeneric 02/2013 - 11/2011
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 11/2011 - 03/2011
2	LigandsIBA 11/2011 - 03/2011
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2024
1	Guanosine Diphosphate (GDP)IBA 12/2023
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	IgA receptor (protein B)IBA 10/2023
1	Surface-Active Agents (Surfactants)IBA 10/2023
1	Indicators and Reagents (Reagents)IBA 10/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	Interleukin-13IBA 04/2023
1	InterleukinsIBA 04/2023
1	EnzymesIBA 01/2023
1	Freund's AdjuvantIBA 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2023
1	triphenyltetrazoliumIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023
1	brain-derived neurotrophic factor precursorIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Connexin 43 (Connexin43)IBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	CytokinesIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	LipopolysaccharidesIBA 10/2022
1	Butyrates (Butyrate)IBA 10/2022
1	VaccinesIBA 07/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2022
1	ChromatinIBA 01/2022
1	AntagomirsIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Circular RNAIBA 12/2021
1	CateninsIBA 12/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Histone Deacetylase InhibitorsIBA 10/2020
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2020
1	AnthracyclinesIBA 06/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Histones (Histone)IBA 01/2018
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2018

Therapy/Procedure

9	Therapeutics 03/2024 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
2	Spinal Injections 01/2023 - 01/2023
2	Subcutaneous Injections 01/2022 - 01/2019
1	Orthodontics 01/2024
1	Traditional Medicine (Folk Remedies) 01/2022